IMPAX LABORATORIES INC (IPXL) has 62 open-market insider trades by 12 insiders since 2009. The most active filer is Nigel Fleming, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Larry Hsu | Dir | — | 10 | $11.0M | 2015-05-12 |
| Michael Markbreiter | Dir | — | 9 | $3.3M | 2015-08-31 |
| Nigel Fleming | Dir | — | 11 | $2.5M | 2015-08-31 |
| Leslie Z. Benet | Dir | — | 9 | $1.3M | 2018-05-04 |
| Allen Chao | Dir | — | 2 | $637K | 2018-05-04 |
| Mark A. Schlossberg | SVP and General Counsel | — | 3 | $541K | 2018-05-04 |
| Robert L. Burr | Dir | — | 2 | $332K | 2018-05-04 |
| Peter R. Terreri | Dir | — | 3 | $307K | 2018-05-04 |
| Michael Nestor | PresImpax Specialty | — | 6 | $298K | 2018-05-04 |
| Charles V. Hildenbrand | SVPOperations | — | 1 | $29K | 2011-05-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Nestor | President & Impax Specialty | Sell | $17K | 2017-05-31 |
| Michael Nestor | President & Impax Specialty | Sell | $14K | 2017-05-17 |
| Michael Nestor | President & Impax Specialty | Sell | $12K | 2017-05-12 |
| Leslie Z. Benet | Director | Sell | $230K | 2016-08-15 |
| Mark A. Schlossberg | SVP and General Counsel | Sell | $323K | 2015-09-11 |
| Michael Nestor | President & Impax Pharm. | Sell |
Companies that share insiders with IPXL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $218K |
| 2015-09-10 |
| Leslie Z. Benet | Director | Sell | $338K | 2015-08-31 |
| Nigel Fleming | Director | Sell | $1.2M | 2015-08-31 |
| Michael Markbreiter | Director | Sell | $754K | 2015-08-28 |
| Peter R. Terreri | Director | Sell | $212K | 2015-08-27 |
| Mark A. Schlossberg | SVP and General Counsel | Sell | $202K | 2015-08-27 |
| Michael Markbreiter | Director | Sell | $819K | 2015-08-25 |
| Larry Hsu | Director | Sell | $2.8M | 2014-06-05 |
| Peter R. Terreri | Director | Sell | $84K | 2014-05-27 |
| Larry Hsu | Director | Sell | $1.4M | 2014-05-22 |